Phenotypic plasticity and the epigenetics of human disease
The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.
Abstract
It is becoming clear that epigenetic changes are involved in human disease as well as during normal development. A unifying theme of disease epigenetics is defects in phenotypic plasticity--cells' ability to change their behaviour in response to internal or external environmental cues. This model proposes that hereditary disorders of the epigenetic apparatus lead to developmental defects, that cancer epigenetics involves disruption of the stem-cell programme, and that common diseases with late-onset phenotypes involve interactions between the epigenome, the genome and the environment. Increased understanding of epigenetic-disease mechanisms could lead to disease-risk stratification for targeted intervention and to targeted therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Research has shown that epigenetic regulation of gene transcription is a key mechanism subserving adaptation to external stimuli at the molecular level 13.”
From Resilience in mental health: linking psychological and neurobiological perspectives. (2013) · cites this paper as [13]
Citations
Cites
Epigenetic programming by maternal behavior
Weaver, I. C. G., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., & Meaney, M. J. (2004) · Nature Neuroscience · doi:10.1038/nn1276 · Cited by 6,177 · cited 1×
“A remarkable example of an environmental effect on the epigenome is the modification of glucocorticoid receptor methylation seen in the hippocampus of rat pups in response to maternal groomin”
BackgroundThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648 · cited 1×
“, and many other tumour suppressor genes, including p16 , VHL (von Hippel–Lindau), MLH1 , APC (adenomatosis polyposis coli) and E-cadherin (see ref”
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602 · cited 1×
“This idea is supported by a study showing greater variance of total DNA methylation and histone H3K9 acetylation in older monozygotic twins than in younger twins, although that study did not measure epigenetic changes over time in the same individua”
ResultThe polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717 · cited 1×
“For example, overexpression of the polycomb group protein EZH2, a H3 lysine-27 (H3K27) histone methyltransferase, is found in metastatic prostate cancer and may lead to widespread transcriptional repressio”
BackgroundEpigenetic Transgenerational Actions of Endocrine Disruptors and Male Fertility
Anway, M. D., Cupp, A. S., Uzumcu, M., & Skinner, M. K. (2005) · Science · doi:10.1126/science.1108190 · Cited by 2,563 · cited 1×
“Oestrogenic and anti-androgenic toxins that decrease male fertility alter DNA methylation, and these changes are inherited by subsequent generation”
BackgroundCpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523 · cited 1×
“Another example of epigenetic alterations in normal tissue is the hypermethylation of p16 that occurs with agein”
BackgroundPolycomb complexes repress developmental regulators in murine embryonic stem cells
Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., et al. (2006) · Nature · doi:10.1038/nature04733 · Cited by 2,514
Autism as a strongly genetic disorder: evidence from a British twin study
Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., & Rutter, M. (1995) · Psychological Medicine · doi:10.1017/s0033291700028099 · Cited by 2,461 · cited 1×
“Only 60p concordance was reported in autism using strict criteri”
MethodHypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437 · cited 1×
“The first epigenetic change described in tumours was gene hypomethylatio”
BackgroundSelf-citationThe history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
Self-citationHsp90 as a capacitor for morphological evolution
Rutherford, S. L., & Lindquist, S. (1998) · Nature · doi:10.1038/24550 · Cited by 2,270 · cited 1×
“First, inhibition of the chaperone protein Hsp90 in Drosophila leads to the expression of previously latent heritable mutations within a single meiotic cell division, which then become independent of Hsp90 (ref”
BackgroundA gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Transposable elements: targets for early nutritional effects on epigenetic gene regulation
Waterland, R. A., & Jirtle, R. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5293-5300.2003 · Cited by 2,019 · cited 1×
“84 ), and methylation supplementation can cause methylation and silencing of a retroposon in mice with silencing of the nearby agouti coat-colour gen”
BackgroundFraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923
The epigenetic progenitor origin of human cancer
Feinberg, A. P., Ohlsson, R., & Henikoff, S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,853 · cited 1×
“Cancer epigenetics and the stem-cell hypothesis Although epigenetic alterations are commonly looked on as surrogates for genetic change in cancer, they are probably also critical first steps in neoplastic progression, disrupting the normal stem- or progenitor-cell programme, for example by stimulating stem-cell prolif…”
BackgroundSelf-citationPhiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758 · cited 1×
“For example, valproic acid is used to treat various disorders, including seizures, bipolar disorder and cancer, and valproic acid was recently found to be a potent histone deacetylase inhibito”
BackgroundWeber, M., Davies, J. J., Wittig, D., Oakeley, E. J., Haase, M., Lam, W. L., & Schübeler, D. (2005) · Nature Genetics · doi:10.1038/ng1598 · Cited by 1,754
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
Versteege, I., Sévenet, N., Lange, J., Rousseau-Merck, M.-F., Ambros, P., Handgretinger, R., Aurias, A., & Delattre, O. (1998) · Nature · doi:10.1038/28212 · Cited by 1,556
Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9
Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., et al. (2006) · Nature · doi:10.1038/nature04980 · Cited by 1,513
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499 · cited 1×
“Hypomethylation also causes increased chromosomal instability, leading to aggressive T-cell lymphoma”
BackgroundChromosomal Instability and Tumors Promoted by DNA Hypomethylation
Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083557 · Cited by 1,399 · cited 1×
“, as well as an increase in sarcomas in mice with p53 and neurofibromin 1 ( NF1 ) mutation”
BackgroundAberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
Petrif, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C. M., Masuno, M., Tommerup, N., van Ommen, G.-J. B., Goodman, R. H., Peters, D. J. M., et al. (1995) · Nature · doi:10.1038/376348a0 · Cited by 1,217 · cited 1×
“Rubinstein–Taybi syndrome involves the CREB (cyclic-AMP responsive-element-binding protein)-binding protein CBP, which has histone acetyltransferase activity, and mutations in CBP lead to skeletal and cardiac malformations, as well as neurodevelopmental malformations and loss of neural plasticit”
BackgroundXu, G.-L., Bestor, T. H., Bourc'his, D., Hsieh, C.-L., Tommerup, N., Bugge, M., Hulten, M., Qu, X., Russo, J. J., & Viegas-Péquignot, E. (1999) · Nature · doi:10.1038/46052 · Cited by 1,203 · cited 1×
“Immunodeficiency/centromeric instability/facial anomalies (ICF) syndrome, for example, affects the immune system and involves mutations of the DNA methyltransferase gene DNMT3B , which is responsible for de novo DNA methylation during developmen”
BackgroundA histone H3 methyltransferase controls DNA methylation in Neurospora crassa
Tamaru, H., & Selker, E. U. (2001) · Nature · doi:10.1038/35104508 · Cited by 1,038
DeBaun, M. R., Niemitz, E. L., & Feinberg, A. P. (2003) · The American Journal of Human Genetics · doi:10.1086/346031 · Cited by 916 · cited 1×
“A surprising environmental modulator of the epigenome is assisted reproductive technology (ART), which has been shown to be the method of conception at higher than expected frequency in Beckwith–Wiedemann syndrome and Angelman syndrom”
MethodSelf-citationDNA hypomethylation and human diseases
Wilson, A. S., Power, B. E., & Molloy, P. L. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.007 · Cited by 804 · cited 1×
“, and we now know that many growth-promoting genes are activated through hypomethylation in tumours, including HRAS , cyclin D2 and maspin in gastric cancer, carbonic anhydrase IX in renal-cell cancer, and S100 calcium-binding protein A4 in colon cancer (see ref”
BackgroundRelaxation of imprinted genes in human cancer
Rainier, S., Johnson, L. A., Dobry, C. J., Ping, A. J., Grundy, P. E., & Feinberg, A. P. (1993) · Nature · doi:10.1038/362747a0 · Cited by 792 · cited 1×
“So it was surprising that the first molecular evidence for a role of genomic imprinting in cancer was loss of imprinting (LOI), causing abnormal activation of the normally silent copy of IGF2 , an important autocrine growth factor, leading to pathological biallelic expression of IGF2 in Wilms' tumours, the most common…”
BackgroundSelf-citationEvidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function
Skuse, D. H., James, R. S., Bishop, D. V. M., Coppin, B., Dalton, P., Aamodt-Leeper, G., Bacarese-Hamilton, M., Creswell, C., McGurk, R., & Jacobs, P. A. (1997) · Nature · doi:10.1038/42706 · Cited by 747
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735 · cited 1×
“, and is associated with a fivefold increased frequency of benign and malignant colorectal neoplasms (and 20-fold for cancer), as well as an increased family history of cancer, consistent with a causal role in cancer predispositio”
BackgroundSelf-citationSuppression of intestinal neoplasia by DNA hypomethylation
Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Edward Jung, W., Li, E., Weinberg, R. A., & Jaenisch, R. (1995) · Cell · doi:10.1016/0092-8674(95)90329-1 · Cited by 710 · cited 1×
“DNA hypermethylation is also important, as DNMT1 hypomorphs also show delayed progression of adenomas in Min mic”
BackgroundRelaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour
Ogawa, O., Eccles, M. R., Szeto, J., McNoe, L. A., Yun, K., Maw, M. A., Smith, P. J., & Reeve, A. E. (1993) · Nature · doi:10.1038/362749a0 · Cited by 707 · cited 1×
“So it was surprising that the first molecular evidence for a role of genomic imprinting in cancer was loss of imprinting (LOI), causing abnormal activation of the normally silent copy of IGF2 , an important autocrine growth factor, leading to pathological biallelic expression of IGF2 in Wilms' tumours, the most common…”
BackgroundVeigl, M. L., Kasturi, L., Olechnowicz, J., Ma, A., Lutterbaugh, J. D., Periyasamy, S., Li, G.-M., Drummond, J., Modrich, P. L., Sedwick, W. D., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8698 · Cited by 648
Haploinsufficiency of NSD1 causes Sotos syndrome
Kurotaki, N., Imaizumi, K., Harada, N., Masuno, M., Kondoh, T., Nagai, T., Ohashi, H., Naritomi, K., Tsukahara, M., Makita, Y., et al. (2002) · Nature Genetics · doi:10.1038/ng863 · Cited by 644 · cited 1×
“Sotos syndrome, which is characterized by tissue overgrowth, leukaemia and Wilms' tumour, is caused by mutations in NSD1 , an H3K36/H4K20 methyltransferas”
BackgroundIyer, N. G., Özdag, H., & Caldas, C. (2004) · Oncogene · doi:10.1038/sj.onc.1207118 · Cited by 638
Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma
Greger, V., Passarge, E., H�pping, W., Messmer, E., & Horsthemke, B. (1989) · Human Genetics · doi:10.1007/bf00286709 · Cited by 574 · cited 1×
“By contrast, tumour suppressor gene silencing has been linked to promoter hypermethylation, first described for RB , the gene associated with retinoblastom”
BackgroundDirect interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication
Estève, P.-O., Chin, H. G., Smallwood, A., Feehery, G. R., Gangisetty, O., Karpf, A. R., Carey, M. F., & Pradhan, S. (2006) · Genes & Development · doi:10.1101/gad.1463706 · Cited by 536
Distinct epigenetic changes in the stromal cells of breast cancers
Hu, M., Yao, J., Cai, L., Bachman, K. E., van den Brûle, F., Velculescu, V., & Polyak, K. (2005) · Nature Genetics · doi:10.1038/ng1596 · Cited by 520 · cited 1×
“In breast cancer, widespread epigenetic alterations are found in tumour cells, stromal cells and the myoepithelium, suggesting that the entire tumour microenvironment, including apparently normal cells, is the target of epigenetic disruptio”
BackgroundLehner, B., Crombie, C., Tischler, J., Fortunato, A., & Fraser, A. G. (2006) · Nature Genetics · doi:10.1038/ng1844 · Cited by 502 · cited 1×
“All were components of chromatin-modifying complexe”
An integrated epigenetic and genetic approach to common human disease
BJORNSSON, H. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.06.009 · Cited by 448 · cited 1×
“The common disease genetic and epigenetic (CDGE) hypothesis argues that in addition to genetic variation, epigenetics provides an added layer of variation that might mediate the relationship between genotype and internal and external environmental factor”
BackgroundThe Human let-7a-3 Locus Contains an Epigenetically Regulated MicroRNA Gene with Oncogenic Function
Brueckner, B., Stresemann, C., Kuner, R., Mund, C., Musch, T., Meister, M., Sültmann, H., & Lyko, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4074 · Cited by 444
DeBaun, M. R., & Tucker, M. A. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70008-3 · Cited by 437 · cited 1×
“The first such example was Beckwith–Wiedemann syndrome, which leads to an 800-fold increased risk of embryonal tumours — that is, those involving residual fetal tissues, such as Wilms' tumour of the kidney and rhabdomyosarcom”
BackgroundPremature ovarian failure in the fragile X syndrome
Sherman, S. L. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(200023)97:3<189::aid-ajmg1036>3.0.co;2-j · Cited by 437
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene
Bachman, K. E., Park, B. H., Rhee, I., Rajagopalan, H., Herman, J. G., Baylin, S. B., Kinzler, K. W., & Vogelstein, B. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00234-9 · Cited by 418
Frigola, J., Song, J., Stirzaker, C., Hinshelwood, R. A., Peinado, M. A., & Clark, S. J. (2006) · Nature Genetics · doi:10.1038/ng1781 · Cited by 409 · cited 1×
“An exciting demonstration of domain-wide silencing involves an entire chromosomal ban”
BackgroundEvidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution
Sollars, V., Lu, X., Xiao, L., Wang, X., Garfinkel, M. D., & Ruden, D. M. (2003) · Nature Genetics · doi:10.1038/ng1067 · Cited by 409 · cited 1×
“This mutational suppression is chromatin mediated and can be reversed by mutations in several trithorax group protein”
BackgroundSparago, A., Cerrato, F., Vernucci, M., Ferrero, G. B., Silengo, M. C., & Riccio, A. (2004) · Nature Genetics · doi:10.1038/ng1410 · Cited by 371 · cited 1×
“In patients with Beckwith–Wiedemann syndrome, microdeletions within each imprinted subdomain have confirmed the regulatory role of these sequences, because individuals with these deletions show loss of normal imprinted gene regulatio”
BackgroundReprogramming of a melanoma genome by nuclear transplantation
Hochedlinger, K., Blelloch, R., Brennan, C., Yamada, Y., Kim, M., Chin, L., & Jaenisch, R. (2004) · Genes & Development · doi:10.1101/gad.1213504 · Cited by 367 · cited 1×
“Further support for the model comes from the fact that mouse melanoma and medulloblastoma nuclei can be cloned to form blastocysts or chimaeric mic”
BackgroundQuddus, J., Johnson, K. J., Gavalchin, J., Amento, E. P., Chrisp, C. E., Yung, R. L., & Richardson, B. C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116576 · Cited by 359 · cited 1×
“Treatment of viable T cells with 5-aza-2′-deoxycytidine induces a syndrome in mice similar to systemic lupus erythematosi”
BackgroundPost-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus
Waterland, R. A., Lin, J.-R., Smith, C. A., & Jirtle, R. L. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi484 · Cited by 337 · cited 1×
“Deficiency in folate and methionine, necessary for normal biosynthesis of S-adenosylmethionine, the methyl donor for methylcytosine, leads to aberrant imprinting of IGF2 (ref”
BackgroundEpigenetics and Assisted Reproductive Technology: A Call for Investigation
Niemitz, E. L., & Feinberg, A. P. (2004) · The American Journal of Human Genetics · doi:10.1086/382897 · Cited by 325 · cited 1×
“Intriguingly, all but 1 of the 14 reported cases of Beckwith–Wiedemann syndrome associated with ART involved hypomethylation of LIT1 (ref”
BackgroundSelf-citationLoss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice
Sakatani, T., Kaneda, A., Iacobuzio-Donahue, C. A., Carter, M. G., de Boom Witzel, S., Okano, H., Ko, M. S. H., Ohlsson, R., Longo, D. L., & Feinberg, A. P. (2005) · Science · doi:10.1126/science.1108080 · Cited by 321
Self-citationThe emerging science of epigenomics
Callinan, P. A., & Feinberg, A. P. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl095 · Cited by 317 · cited 1×
“This idea can be tested by incorporating an assessment of the epigenome into population epidemiological studies (see ref”
MethodSelf-citation(2003) · PubMed · Cited by 313
Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized
Bienvenu, T., & Chelly, J. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1878 · Cited by 289 · cited 1×
“In Rett syndrome, DNA methylation proceeds normally but epigenetic silencing is impaired because of a failure to properly recognize this mar”
BackgroundLoss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability
Cui, H., Horon, I. L., Ohlsson, R., Hamilton, S. R., & Feinberg, A. P. (1998) · Nature Medicine · doi:10.1038/3260 · Cited by 284 · cited 1×
“LOI of IGF2 was found in adults, at a frequency of 5–10&percnt”
BackgroundSelf-citationDeBaun, M. R., Niemitz, E. L., McNeil, D. E., Brandenburg, S. A., Lee, M. P., & Feinberg, A. P. (2002) · The American Journal of Human Genetics · doi:10.1086/338934 · Cited by 276 · cited 1×
“Some patients with Beckwith–Wiedemann syndrome show loss of imprinting of IGF2 , which leads to a double dose of this autocrine factor, resulting in tissue overgrowth and increased cancer ris”
BackgroundSelf-citationHypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis
Wu, H., Chen, Y., Liang, J., Shi, B., Wu, G., Zhang, Y., Wang, D., Li, R., Yi, X., Zhang, H., et al. (2005) · Nature · doi:10.1038/nature04225 · Cited by 273
Epigenetics and the Environment
SUTHERLAND, J. E., & COSTA, M. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05970.x · Cited by 261 · cited 1×
“Environmental toxins such as heavy metals disrupt DNA methylation and chromati”
BackgroundA model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting.
Scrable, H., Cavenee, W., Ghavimi, F., Lovell, M., Morgan, K., & Sapienza, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7480 · Cited by 261 · cited 1×
“Molecular evidence for a role of genomic imprinting in cancer emerged from studies showing a universal loss of the maternal allele in Wilms' tumours and embryonal rhabdomyosarcoma, with loss of heterozygosity (LOH) of 11p15, implying that normally only the maternal allele of an as yet unidentified tumour suppressor ge…”
BackgroundFrom Epigenesis to Epigenetics: The Case of C. H. Waddington
Van Speybroeck, L. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04912.x · Cited by 260 · cited 1×
“jpg" NDATA ITEM> ]> The original definition of epigenetics by Waddington in 1942 (ref”
Global loss of imprinting leads to widespread tumorigenesis in adult mice
Holm, T. M., Jackson-Grusby, L., Brambrink, T., Yamada, Y., Rideout, W. M., & Jaenisch, R. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.007 · Cited by 250 · cited 1×
“Moreover, engineered global LOI leads to intestinal and hepatic tumours in chimaeric mic”
BackgroundActivation of mouse genes in transformed cells
Scott, M. R. D., Westphal, K.-H., & Rigby, P. W. J. (1983) · Cell · doi:10.1016/0092-8674(83)90388-4 · Cited by 247
Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis
Yamada, Y., Jackson-Grusby, L., Linhart, H., Meissner, A., Eden, A., Lin, H., & Jaenisch, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506612102 · Cited by 245 · cited 1×
“When DNMT1 hypomorphs are crossed with Min (multiple intestinal neoplasia) mice with an Apc mutation, they show an increased frequency of intestinal neoplasia and liver cancer”
BackgroundRozenblatt–Rosen, O., Rozovskaia, T., Burakov, D., Sedkov, Y., Tillib, S., Blechman, J., Nakamura, T., Croce, C. M., Mazo, A., & Canaani, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4152 · Cited by 239
Molecular-clinical spectrum of the ATR-X syndrome
Gibbons, R. J., & Higgs, D. R. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(200023)97:3<204::aid-ajmg1038>3.0.co;2-x · Cited by 233
DNA methylation and autoimmune disease
Richardson, B. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00206-7 · Cited by 220 · cited 1×
“Procainamide and hydralazine both cause hypomethylation and can cause lupus, and treatment of T cells with these drugs elicits a lupus-like syndrome in mic”
BackgroundKondo, M., Suzuki, H., Ueda, R., Osada, H., Takagi, K., Takahashi, T., & Takahashi, T. (1995) · PubMed · Cited by 209
Terranova, R., Agherbi, H., Boned, A., Meresse, S., & Djabali, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507425103 · Cited by 208
From epigenesis to epigenetics: the case of C. H. Waddington.
Speybroeck, L. V. (2002) · PubMed · Cited by 208
Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors
Chen, W. Y., Zeng, X., Carter, M. G., Morrell, C. N., Chiu Yen, R.-W., Esteller, M., Watkins, D. N., Herman, J. G., Mankowski, J. L., & Baylin, S. B. (2003) · Nature Genetics · doi:10.1038/ng1077 · Cited by 201
Imprinting defects on human chromosome 15
Horsthemke, B., & Buiting, K. (2006) · Cytogenetic and Genome Research · doi:10.1159/000090844 · Cited by 195 · cited 1×
“Microdeletions in patients with both Prader–Willi syndrome and Angelman syndrome reveal the location of the domain that regulates imprinting of both gene”
BackgroundGenomic imprinting and gene activation in cancer
Feinberg, A. P. (1993) · Nature Genetics · doi:10.1038/ng0693-110 · Cited by 181 · cited 1×
“LOI refers either to aberrant activation of the normally silent allele of an imprinted growth-promoting gene, or aberrant silencing of the normally expressed copy of an imprinted tumour suppressor gene, such as the still unidentified locus on 11p15 (ref”
BackgroundSelf-citationGius, D., Cui, H., Bradbury, C. M., Cook, J., Smart, D. K., Zhao, S., Young, L., Brandenburg, S. A., Hu, Y., Bisht, K. S., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.029 · Cited by 181 · cited 1×
“It should also be noted that as many genes are silenced as are activated in tumours by both drug-induced hypomethylation and by knockdown of DNA methyltransferase”
BackgroundSelf-citationFurther characterization of the autism susceptibility locus AUTS1 on chromosome 7q
International Molecular Genetic Study of Autism Consortium (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.973 · Cited by 174
Ravenel, J. D., Broman, K. W., Perlman, E. J., Niemitz, E. L., Jayawardena, T. M., Bell, D. W., Haber, D. A., Uejima, H., & Feinberg, A. P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1698 · Cited by 172
Self-citationAlcohol, One-Carbon Metabolism, and Colorectal Cancer: Recent Insights from Molecular Studies
Giovannucci, E. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.9.2475s · Cited by 161
Identification of a cluster of X-linked imprinted genes in mice
Raefski, A. S., & O’Neill, M. J. (2005) · Nature Genetics · doi:10.1038/ng1567 · Cited by 151 · cited 1×
“, and a candidate imprinted gene region that could be responsible has been identifie”
BackgroundMcInnis, M. G., Lan, T.-H., Willour, V. L., McMahon, F. J., Simpson, S. G., Addington, A. M., MacKinnon, D. F., Potash, J. B., Mahoney, A., Chellis, J., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001277 · Cited by 139
Neuroanatomic Variation in Monozygotic Twin Pairs Discordant for the Narrow Phenotype for Autism
Kates, W. R., Burnette, C. P., Eliez, S., Strunge, L. A., Kaplan, D., Landa, R., Reiss, A. L., & Pearlson, G. D. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.539 · Cited by 137 · cited 1×
“, and neuroanatomical differences have been found in cerebellar grey- and white-matter volumes between discordant monozygotic twin”
BackgroundAstuti, D., Latif, F., Wagner, K. J., Gentle, D., Cooper, W. N., Catchpoole, D. R., Grundy, R. G., Ferguson‐Smith, A. C., & Maher, E. R. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602478 · Cited by 136
Murphy, S. K., Huang, Z., Wen, Y., Spillman, M. A., Whitaker, R. S., Simel, L. R., Nichols, T. D., Marks, J. R., & Berchuck, A. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0138 · Cited by 136
Microdeletion of LIT1 in Familial Beckwith-Wiedemann Syndrome
Niemitz, E. L., DeBaun, M. R., Fallon, J., Murakami, K., Kugoh, H., Oshimura, M., & Feinberg, A. P. (2004) · The American Journal of Human Genetics · doi:10.1086/425343 · Cited by 131 · cited 1×
“In patients with Beckwith–Wiedemann syndrome, microdeletions within each imprinted subdomain have confirmed the regulatory role of these sequences, because individuals with these deletions show loss of normal imprinted gene regulatio”
BackgroundSelf-citationKato, T., Iwamoto, K., Kakiuchi, C., Kuratomi, G., & Okazaki, Y. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001662 · Cited by 128
Epigenetics, disease, and therapeutic interventions
Lu, Q., Qiu, X., Hu, N., Wen, H., Su, Y., & Richardson, B. C. (2006) · Ageing Research Reviews · doi:10.1016/j.arr.2006.07.001 · Cited by 125 · cited 1×
“Aberrant hypomethylation is found in T cells of patients with systemic lupus erythematosis, including in genes such as lymphocyte function-associated antigen-1, which is overexpressed in lupus T cell”
BackgroundEpigenetic Cancer Therapy Makes Headway
Mack, G. S. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj447 · Cited by 110
Yuan, J., Luo, R. Z.-T., Fujii, S., Wang, L., Hu, W., Andreeff, M., Pan, Y., Kadota, M., Oshimura, M., Şahin, A. A., et al. (2003) · PubMed · Cited by 95
Defective B-cell-negative selection and terminal differentiation in the ICF syndrome
Blanco-Betancourt, C., Moncla, A., Milili, M., Jiang, Y., Viégas-Pèquignot, E., Roquelaure, B., Thuret, I., & Schiff, C. (2003) · Blood · doi:10.1182/blood-2003-08-2632 · Cited by 91
Frequent loss of imprinting of PEG1/MEST in invasive breast cancer.
Pedersen, I. S., Dervan, P. A., Broderick, D., Harrison, M., Miller, N., Delany, E., O'Shea, D., Costello, P., McGoldrick, A., Keating, G., et al. (1999) · PubMed · Cited by 91
Inborn errors of development : the molecular basis of clinical disorders of morphogenesis
Epstein, C. J., Erickson, R. P., & Wynshaw-Boris, A. J. (2004) · Cited by 88
Inborn Errors of Development: The Molecular Basis of Clinical Disorders of Morphogenesis.
Neidich, J. (2005) · The American Journal of Human Genetics · doi:10.1086/427893 · Cited by 87
Preference of DNA Methyltransferases for CpG Islands in Mouse Embryonic Stem CellsPreprint
Hattori, N., Abe, T., Hattori, N., Suzuki, M., Matsuyama, T., Yoshida, S., Li, E., & Shiota, K. (2004) · Genome Research · doi:10.1101/gr.2431504 · Cited by 80 · cited 1×
“However, studies focused on loss of DNA methylation in cancer may have overlooked hypomethylation of tissue-specific methylation marks at CpG island”
BackgroundWoodson, K. G., Flood, A. P., Green, L. D., Tangrea, J. A., Hanson, J., Cash, B. D., Schatzkin, A. G., & Schoenfeld, P. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh042 · Cited by 78
Horton, S. J., Grier, D. G., McGonigle, G. J., Thompson, A., Morrow, M., Silva, I. D., MOULDING, D. A., Kioussis, D., Lappin, T. R. J., Brady, H. J. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1691 · Cited by 71 · cited 1×
“The gene MLL1 , which is rearranged and activated in childhood leukaemias, is also a key regulator of normal stem-cell differentiatio”
Backgroundvan Roozendaal, C. E. P., Gillis, A., Klijn, J. G. M., Ooijen, B. V., Claassen, C., Eggermont, A. M. M., Henzen-Logmans, S. C., Oosterhuis, J. W., Foekens, J. A., & Looijenga, L. H. J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01211-3 · Cited by 65
IGF2 but not H19 shows loss of imprinting in human glioma.
Uyeno, S., Aoki, Y., Nata, M., SAGISAKA, K., Kayama, T., Yoshimoto, T., & Ono, T. (1996) · PubMed · Cited by 63
Harper, J., Burns, J. L., Foulstone, E. J., Pignatelli, M., Zaina, S., & Hassan, A. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2036 · Cited by 60 · cited 1×
“LOI of IGF2 leads to an expanded progenitor-cell compartment in the intestine of mice harbouring an Apc mutation, and increased expression of progenitor-cell marker”
BackgroundSelective HAT Inhibitors as Mechanistic Tools for Protein Acetylation
Zheng, Y. G., Thompson, P. R., Cebrat, M., Wang, L., Devlin, M. K., Alani, R. M., & Cole, P. A. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)76012-1 · Cited by 40 · cited 1×
“An effect opposite to that of methyltransferase and histone deacetylase inhibitors is achieved through rational drug design of histone acetyltransferase inhibitors, for example, bisubstrate analogues such as Lys-CoA, a selective p300 / CBP inhibito”
BackgroundAlternative mechanisms associated with silencing of CDKN1C in Beckwith–Wiedemann syndrome
Diaz-Meyer, N., Yang, Y., Sait, S. N. J., Maher, E. R., & Higgins, M. J. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.030593 · Cited by 26 · cited 1×
“Other patients with this syndrome show localized abnormalities of allele-specific chromatin modificatio”
BackgroundLalande, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12645 · Cited by 25 · cited 1×
“PHPIA is a more severe phenotype of multiple hormone resistance caused by tissue-specific differential imprinting of splice variants of the same gen”
BackgroundClinical experience with decitabine in North American patients with myelodysplastic syndrome
Yee, K. W. L., Jabbour, E. J., Kantarjian, H. M., & Giles, F. J. (2005) · Annals of Hematology · doi:10.1007/s00277-005-0019-7 · Cited by 8 · cited 1×
“The overall response rate with decitabine in a phase III study showed a small but statistically significant difference for myelodysplasia (9p complete response and 8p partial response, compared with no response in controls), and half of the clinically responsive patients showed a cytogenetic respons”
Background
Cited by
Aryee, M. J., Jaffe, A. E., Corrada-Bravo, H., Ladd-Acosta, C., Feinberg, A. P., Hansen, K. D., & Irizarry, R. A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu049 · Cited by 4,397
“The health implications of deciphering the DNAm code have recently received much attention (Dawson and Kouzarides, 2012; Feinberg, 2007).”
Self-citationWallace, D. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3365 · Cited by 2,404
The NIH Roadmap Epigenomics Mapping Consortium
Bernstein, B. E., Stamatoyannopoulos, J. A., Costello, J. F., Ren, B., Milosavljevic, A., Meissner, A., Kellis, M., Marra, M. A., Beaudet, A. L., Ecker, J. R., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt1010-1045 · Cited by 1,892
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805
Taverna, S. D., Li, H., Ruthenburg, A. J., Allis, C. D., & Patel, D. J. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1338 · Cited by 1,418
“It has become increasingly clear that epigenetic changes, such as DNA and histone methylation, contribute to the progression of human disease (see ref”
Background
Metadata
- Authors
- Feinberg, A. P.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Feinberg, Andrew P.
- ORCID
- Feinberg, Andrew P.
- Venue
- Nature
- Published
- 2007-05-23
- Volume
- 447
- Issue
- 7143
- Pages
- 433-440
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2033102369
- Cited by
- 1,613
- References
- 104
- Citations by year
- 2026: 25 · 2025: 34 · 2024: 33 · 2023: 52 · 2022: 57 · 2021: 60 · 2020: 66 · 2019: 87 · 2018: 54 · 2017: 90 · 2016: 99 · 2015: 113 · 2014: 97 · 2013: 124 · 2012: 131
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R37CA054358, R01CA054358)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- phenotypic plasticity, epigenetics, human disease, developmental defects, cancer epigenetics, gene-environment interaction, disease risk stratification, targeted therapy
- MeSH terms
- Chromatin, Environment, Humans, Neoplasms, Genomic Imprinting, DNA Methylation, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.